Bruker (NASDAQ: BRKR) reported Q2 EPS of $0.32, $0.10 worse than the analyst estimate of $0.42. Revenue for the quarter came in at $797.4 million versus the consensus estimate of $812.81 million.

GUIDANCE:

Bruker sees FY2025 EPS of $1.95-$2.05, versus the consensus of $2.42. Bruker sees FY2025 revenue of $3.43-3.5 billion, versus the consensus of $3.52 billion.

For earnings history and earnings-related data on Bruker (BRKR) click here.